PRESS RELEASE
January 2009
New Purpose Built UK Crime Scene Laboratory
Eurofins Forensic Services in pleased to announce the approval of its purpose built UK Crime Scene laboratory for the submission of DNA samples to the UK National DNA Database. This follows the company’s successful accreditation by the Custodian Accreditation Service (CAS) and the United Kingdom Accreditation Service (UKAS) to ISO 17025.
The DNA laboratory operating out of Wales specialises in the analysis of crime scene stains and is an important step in Eurofins' strategic development and continued investment within the UK forensic market.
Emma Millican, Director of Eurofins Forensic Services “Our new laboratory complements the
growing network of Eurofins’ specialist forensic DNA and Toxicology laboratories, enabling us
to provide the most comprehensive range of independent and innovative analytical testing
solutions to police forces, legal and criminal justice organisations throughout Europe”
This latest development continues Eurofins objectives of providing its customers with the highest levels of quality, safety and analytical excellence, whilst meeting the demands of regulatory authorities for the submission of court admissible results.
--- End ---
No. of words - 164
Contact Details:
Eurofins Forensic Services
Imperial House
Imperial Way
Newport
NP10 8UH
www.eurofinsforensics.co.uk
Notes for the editor:
Eurofins Forensic Services – Specialist Analysis
Eurofins Forensic Services specialises in the provision of forensic DNA and toxicological testing and support services to police, legal, and criminal justice organisations within the UK.
Eurofins – a global leader in bio-analysis
Eurofins Forensic Services is part of Eurofins Scientific, a life sciences company operating internationally to provide a comprehensive range of analytical testing services to clients from a variety of industries including the pharmaceutical, food and environmental sectors.
With over 7,000 staff in more than 100 laboratories across 29 countries, Eurofins offers a portfolio of over 25,000 reliable analytical methods for evaluating the authenticity, origin, safety, identity, composition and purity of biological substances and products. The Group is committed to provide its customers with high quality services, accurate results in time and, if requested, expert advice by our highly qualified staff.
The Eurofins Group is one of the global market leaders in this field of applied life sciences. It intends to pursue its dynamic growth strategy and expand both its technology portfolio and its geographic reach. Through R&D, inlicensing and acquisitions, the Group draws on the latest developments in the field of biotechnology to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international player in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris (ISIN FR0000038259) and Frankfurt (WKN 910251) Stock Exchanges (Reuters EUFI.LN, Bloomberg ERF FP, ESF, EUFI.DE).
